← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1996Last known activity
Feb 28, 2026
Timeline
1840s
- Jan 1, 1848
Melbourne Health— Founded
Drugs by trial phase (91 distinct, 70 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 3 (31 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Alcohol Drinking
- Alcoholism
- Anxiety Disorders
- Aspergillosis
- Asthma
- Atrial Fibrillation
- Atrial Flutter
- Bipolar Disorder
- Breast Neoplasms
- Candidiasis
- Candidiasis, Invasive
- Cerebral Hemorrhage
- Cerebral Infarction
- Cognitive Dysfunction
- Colorectal Neoplasms
- Communicable Diseases
- Critical Illness
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetic Nephropathies
- Diabetic Retinopathy
- Disease
- Emergencies
- Epidermolysis Bullosa
- Epilepsy, Complex Partial
- Fabry Disease
- Glomerulonephritis
- Hematologic Neoplasms
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- HIV Infections
- Hyperglycemia
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Invasive Fungal Infections
- Ischemia
- Kidney Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Mental Disorders
- Multiple Myeloma
- Multiple Sclerosis
- Mycoses
- Myeloproliferative Disorders
- Myocardial Infarction
- Neoplasms
- Neoplasms, Plasma Cell
- Oliguria
- Parasomnias
- Parkinson Disease
- Polycythemia
- Polycythemia Vera
- Primary Myelofibrosis
- Proteinuria
- Psychotic Disorders
- Recurrence
- Renal Insufficiency
- Retinal Diseases
- Schizophrenia
- Sclerosis
- Shock
- Shock, Septic
- Sleep Initiation and Maintenance Disorders
- Sleep Wake Disorders
- Stroke
- Substance-Related Disorders
- Syndrome
- Systemic Inflammatory Response Syndrome
- Thrombocythemia, Essential
- Thrombocytosis
- Thrombosis
- Tremor
- Vasoplegia
- Venous Thrombosis
Recent trials (50)
- NCT07225465CollaboratorPhase 2Feb 28, 2026
- NCT06607367Lead sponsorPhase 1/Phase 2Oct 30, 2024
- NCT05813223CollaboratorEarly Phase 1Dec 1, 2023
- NCT05923476Lead sponsorEarly Phase 1Jun 1, 2023
- NCT05742243Lead sponsorPhase 2Feb 13, 2023
- NCT05742243Overall official - principal investigatorPhase 2Feb 13, 2023
- NCT05509153Overall official - principal investigatorPhase 2Nov 1, 2022
- NCT05577416Lead sponsorEarly Phase 1Oct 11, 2022
- NCT05577416Overall official - principal investigatorEarly Phase 1Oct 11, 2022
- NCT05199324CollaboratorPhase 3Apr 1, 2022
- NCT05005299Lead sponsorPhase 1Jan 31, 2022
- NCT05005299Overall official - principal investigatorPhase 1Jan 31, 2022
- NCT04796636Lead sponsorPhase 1Sep 27, 2021
- NCT04796636Overall official - principal investigatorPhase 1Sep 27, 2021
- NCT04483960Study chairPhase 3Jul 28, 2020
Details
- Founded
- Parkville, AU Jan 1, 1848
- Last known activity
- Feb 28, 2026